An interventional study of Online vestibular rehabilitation tool and Standard care (written instructions leaflet) in Acute Vestibular Syndrome, sponsored by Umeå University. Completed at 9 sites in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-03-30.
Sponsored by Umeå University · Not applicable, Interventional, and Treatment
Acute onset vertigo is common and entails much suffering with persisting symptoms at 3 months after onset in up to half of those afflicted. Vestibular rehabilitation to aid recovery is not readily available. The purpose of this study is to investigate the effects on vertigo symptoms of a 6-week online vestibular rehabilitation tool compared with standard care (written instructions leaflet) after acute onset vertigo.
248 studies on the registry are indexed under Vertigo; 39 are open to participants now.
This study's enrollment of 184 is above the median of 57 across 186 interventional studies indexed under Vertigo.
Browse Vertigo studies →Umeå University is the lead sponsor of 263 studies on the registry; 60 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Device: Online vestibular rehabilitation tool
Other: Standard care (written instructions leaflet)
For those randomized to the intervention group, a 6 weeks duration vestibular rehabilitation will be delivered using an online tool (YrselTräning)
For those randomized to the control group, a 6 weeks duration standard vestibular rehabilitation will be delivered using a written instructions leaflet
The between group mean Vertigo Symptom Scale Short Form (VSS-SF) score difference
VSS-SF uses a five-point Likert scale: 0 (never), 1 (a few times), 2 (several times), 3 (quite often \[every week\]), and 4 (very often \[most days\]). The score ranges from 0 to 60. A higher score indicates worse symptoms.
Time frame: 6 weeks after vertigo onset
The between groups mean Dizziness Handicap Inventory (DHI) score
The Dizziness Handicap Inventory (DHI) uses a three-point scale to rate each item: 0 (no), 2 (sometimes), and 4 (always). The score ranges from 0 to 100. A higher overall score indicates more severe handicap.
Time frame: 6 weeks and 3 months after vertigo onset
The between groups changes in timed 25-foot walk test (T25-FW)); body sway during standing and walking; and the mobility
Time frame: From baseline to 6 weeks and 3 months
The between groups changes in video head impulse test (vHIT, site-dependent)
Time frame: 6 weeks and 3 months after vertigo onset
The between groups changes in video head impulse test (vHIT, site-dependent) measured lateral canal VOR gain and saccades
Time frame: From baseline to 6 weeks and 3 months
The between groups mean vertigo symptom scale short form (VSS-SF) score
VSS-SF uses a five-point Likert scale: 0 (never), 1 (a few times), 2 (several times), 3 (quite often \[every week\]), and 4 (very often \[most days\]). The score ranges from 0 to 60. A higher score indicates worse symptoms.
Time frame: 12 months after vertigo onset
The between group pedometer-derived mean weekly number of steps walked since last visit
Time frame: 3 months after vertigo onset
The between groups mean number of weekly training sessions
Time frame: 6 weeks after vertigo onset
Register-based search for health economic effects on all levels of care (primary, specialized) and society (sick leave)
Time frame: 12 months
The difference in kinematic output between measurement systems (i.e., multi-sensor and mobile app)
Time frame: Three months after symptom onset
The reliability of the Swedish VSS-SF translation
Time frame: Six weeks after symptom onset
The frequency of BPPV at 6 weeks and 3 months after AVS onset using a BPPV specific questionnaire and positional nystagmus tests
Time frame: 6 weeks and 3 months after vertigo onset
The proportion of participants who has experienced falls/fractures since study start
Time frame: 6 weeks, 3 months and 12 months
The number of falls/fractures in each study arm
Time frame: 6 weeks, 3 months and 12 months
Plan to share: No
This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Umeå University